MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS.

Hansen B. E., Vandriel S. M., Vig P., Garner W., Loomes K. M., Piccoli D. A., ...Daha Fazla

NASPGHAN 2022 Annual Meeting, 12 - 15 Ekim 2022, ss.211-213

  • Yayın Türü: Bildiri / Özet Bildiri
  • Sayfa Sayıları: ss.211-213
  • İstanbul Üniversitesi Adresli: Evet